Trading Report: Today, Hanwha Q Cells Co. Ltd. (HQCL) Receives “Neutral” Rating from Roth Capital

Today, Hanwha Q Cells Co. Ltd. (HQCL) Receives “Neutral” Rating from Roth Capital

Roth Capital reissued their neutral rating on shares of Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL) in a research report sent to investors on Monday. They currently have a $10.00 price target on the stock, down from their prior price target of $13.00.

Separately, Zacks Investment Research raised shares of Hanwha Q Cells Co. from a hold rating to a buy rating and set a $13.00 price target for the company in a research report on Friday, October 14th.

Shares of Hanwha Q Cells Co. (NASDAQ:HQCL) opened at 8.79 on Monday. The company has a market cap of $731.17 million, a P/E ratio of 4.00 and a beta of 2.75. The company’s 50 day moving average is $10.55 and its 200-day moving average is $12.21.

Hanwha Q Cells Co. (NASDAQ:HQCL) last released its quarterly earnings results on Tuesday, November 22nd. The company reported $0.50 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.21 by $0.29. The business earned $707.80 million during the quarter, compared to analyst estimates of $653.40 million. Hanwha Q Cells Co. had a net margin of 6.73% and a return on equity of 42.02%. The firm’s revenue was up 65.7% on a year-over-year basis. On average, equities research analysts anticipate that Hanwha Q Cells Co. will post $1.67 EPS for the current year.

Several institutional investors have recently made changes to their positions in the stock. Morgan Stanley raised its position in shares of Hanwha Q Cells Co. by 12.8% in the third quarter. Morgan Stanley now owns 181,537 shares of the company’s stock valued at $2,035,000 after buying an additional 20,545 shares during the last quarter. KBC Group NV raised its position in shares of Hanwha Q Cells Co. by 36.3% in the third quarter. KBC Group NV now owns 17,098 shares of the company’s stock valued at $192,000 after buying an additional 4,554 shares during the last quarter. Guggenheim Capital LLC raised its position in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock valued at $7,108,000 after buying an additional 107,408 shares during the last quarter. Walleye Trading LLC raised its position in shares of Hanwha Q Cells Co. by 1,166.7% in the second quarter. Walleye Trading LLC now owns 7,600 shares of the company’s stock valued at $109,000 after buying an additional 7,000 shares during the last quarter. Finally, AJO LP bought a new position in shares of Hanwha Q Cells Co. during the second quarter valued at approximately $171,000. 1.29% of the stock is owned by hedge funds and other institutional investors.

Hanwha Q Cells Co. Company Profile

Related posts

Leave a Comment